CYP2C9 polymorphism: prevalence in healthy and warfarin-treated Malay and Chinese in Malaysia
Introduction: Genetic polymorphisms of CYP2C9 among different populations in different geographical regions could be dif ferent . CYP2C9 has been reported to be the enzyme responsible for the metabolism of many drugs, including warfarin and other drugs with a narrow therapeutic index. Realisin...
Main Authors: | Ngow, Harris Abdullah, Wan Khairina, Wan Mohd Nowalid, Teh , Lay Kek, Lee, Wee Leng, Harun, Roslan, Ismail, Rusli, Salleh, Mohd Zaki |
---|---|
Format: | Article |
Language: | English |
Published: |
Singapore Medical Association
2009
|
Subjects: | |
Online Access: | http://irep.iium.edu.my/5194/ http://irep.iium.edu.my/5194/ http://irep.iium.edu.my/5194/1/CYP2C9_Poly_in_SMJ_2009.pdf |
Similar Items
-
VKORC1 Haplotypes in patients treated with warfarin
by: Beshna, E, et al.
Published: (2010) -
Lack of correlation between INR and warfarin dose: a role of pharmacogenotyping of CYP2C9*3 and VKORC1 for anticoagulation
by: Salleh, Mohd Zaki, et al.
Published: (2009) -
The role of pharmacogenetic variation in metoprolol CYP2D6 genotypes polymorphism
by: Wan Sulaiman, Wan Mohd. Azizi, et al.
Published: (2011) -
Role of pharmacodiagnostic of CYP2C9 variants in the optimization of warfarin therapy in Malaysia: a 6-month follow-up study
by: Ngow, Harris Abdullah, et al.
Published: (2008) -
Genetic Polymorphism of CYP2D6 and MDR1 in breast cancer patients treated with tamoxifen
by: Mohamad, NI, et al.
Published: (2010)